Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients

Phase 2 Completed 9 enrolled The University of Texas Health Science Center, Houston

NaSingle-groupOpen-labelTreatment

Summary

The primary goal of the project is to study the effect of Ketamine on cortical neurophysiological function in TRD patients. The proposal employs robust and non-invasive neurophysiological techniques TMS and EEG to investigate the cortical excitability and oscillatory activity in patients with treatment resistant depression.

Timeline

Start: 2016-10-14
Primary completion: 2017-08-16
Completion: 2017-08-16

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ketamine	Small molecule	0.5 mg/kg	Intravenous

Indications

No indication recorded.